CVRX
NASDAQ
$4.77
CVRx Inc (CVRX)
CVRx, Inc. develops implantable technology for the treatment of patients with high blood pressure / hypertension and heart failure.
Sector:
Healthcare
Industry:
Medical Devices
Buy
Target: $11.17 (+134.17%)
Market Cap
$139M
Free Cash Flow Yield
-28.83%
Beta (5Y)
1.57
Price Chart
Valuation
Market Cap$139M
P/S2.37
P/B4.70
Profitability
Total Revenue (TTM)$59M
Gross Profit (TTM)$51M
EBITDA-$49M
Profit Margin-88.8%
Operating Margin-82.3%
EPS-$2.00
Financial Health
Debt-to-Equity200.9%
Free Cash Flow Yield-28.83%
Growth & Risk
Beta (5Y)1.57
Sharpe Ratio-0.38